Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Practical Comparison of Two- and Three-Phase Bearingless Permanent Magnet Slice Motors for Blood Pumps.

Actuators·2026

Same author

Activation Mechanism Design for a Dual-Blood Pumping System for Pediatric Heart Failure.

Artificial organs·2025

Same author

Advancement of the Dragon Heart 7-Series for Pediatric Patients With Heart Failure.

Artificial organs·2025

Same author

Pediatric Cardiovascular Multiscale Modeling using a Functional Mock-up Interface.

Cardiovascular engineering and technology·2025

Same author

Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.

European heart journal·2024

Same author

Series Multiblood Pump Design With Dual Activation for Pediatric Patients With Heart Failure.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2024

Search research articles

Related Experiment Video

Updated: Apr 3, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Total Artificial Hearts-Past, Current, and Future.

Carson S Fox¹, Kelli L McKenna¹, Paul E Allaire²

¹From the BioCirc Research Laboratory, School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania.

Journal of Cardiac Surgery

|September 26, 2015

Summary

This summary is machine-generated.

This review covers the history of total artificial hearts (TAHs) and explores innovative developments, such as using ventricular assist devices (VADs) for biventricular TAH support.

More Related Videos

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Implantation of Total Artificial Heart in Congenital Heart Disease

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Experiment Videos

Last Updated: Apr 3, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Implantation of Total Artificial Heart in Congenital Heart Disease

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Area of Science:

Cardiovascular Engineering
Biomedical Devices
Medical Technology

Background:

Total artificial hearts (TAHs) are critical for end-stage heart failure treatment.
The evolution of TAHs has been marked by significant technological advancements.
Current limitations necessitate novel approaches to biventricular support.

Purpose of the Study:

To review the historical development of total artificial hearts (TAHs).
To explore emerging trends and future directions in TAH technology.
To examine the potential of coupling ventricular assist devices (VADs) for biventricular TAH applications.

Main Methods:

Literature review of TAH evolution.
Analysis of current research in TAH development.
Exploration of novel concepts in cardiac support.

Main Results:

TAH technology has progressed significantly over decades.
New designs are focusing on improved biocompatibility and efficiency.
Coupling VADs presents a promising strategy for comprehensive biventricular support.

Conclusions:

The field of TAHs is rapidly advancing.
Innovative solutions like VAD coupling are poised to enhance TAH capabilities.
Future TAH development will likely incorporate integrated biventricular strategies.